AU Stock MarketDetailed Quotes

MDCDA Medlab Clinical Ltd

Watchlist
  • 0.000
  • 0.0000.00%
20min DelayMarket Closed Aug 6 10:00 AET
0Market Cap0.00P/E (Static)

Medlab Clinical Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2021
(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities
-8.82%8.17M
8.96M
Revenue from customers
-25.87%4.81M
--6.48M
Other cash income from operating activities
35.77%3.37M
--2.48M
Cash paid
4.46%-18.41M
-19.27M
Payments to suppliers for goods and services
4.46%-18.41M
---19.27M
Direct interest paid
29.51%-139.07K
---197.29K
Direct interest received
-69.31%25.2K
--82.09K
Operating cash flow
0.67%-10.35M
---10.42M
Investing cash flow
Cash flow from continuing investing activities
65.90%-82.9K
-243.08K
Net PPE purchase and sale
65.73%-83.3K
---243.08K
Net other investing changes
--404
----
Cash from discontinued investing activities
Investing cash flow
65.90%-82.9K
---243.08K
Financing cash flow
Cash flow from continuing financing activities
77.98%14.81M
8.32M
Net issuance payments of debt
97.24%-26.39K
---954.42K
Net common stock issuance
57.10%15.45M
--9.83M
Net other financing activities
-9.63%-612.36K
---558.59K
Cash from discontinued financing activities
Financing cash flow
77.98%14.81M
--8.32M
Net cash flow
Beginning cash position
-20.79%9.06M
--11.44M
Current changes in cash
286.61%4.37M
---2.34M
Effect of exchange rate changes
91.72%-2.88K
---34.73K
End cash Position
48.24%13.43M
--9.06M
Free cash from
2.15%-10.44M
---10.67M
Accounting Standards
US-GAAP
US-GAAP
(FY)Jun 30, 2021(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities -8.82%8.17M8.96M
Revenue from customers -25.87%4.81M--6.48M
Other cash income from operating activities 35.77%3.37M--2.48M
Cash paid 4.46%-18.41M-19.27M
Payments to suppliers for goods and services 4.46%-18.41M---19.27M
Direct interest paid 29.51%-139.07K---197.29K
Direct interest received -69.31%25.2K--82.09K
Operating cash flow 0.67%-10.35M---10.42M
Investing cash flow
Cash flow from continuing investing activities 65.90%-82.9K-243.08K
Net PPE purchase and sale 65.73%-83.3K---243.08K
Net other investing changes --404----
Cash from discontinued investing activities
Investing cash flow 65.90%-82.9K---243.08K
Financing cash flow
Cash flow from continuing financing activities 77.98%14.81M8.32M
Net issuance payments of debt 97.24%-26.39K---954.42K
Net common stock issuance 57.10%15.45M--9.83M
Net other financing activities -9.63%-612.36K---558.59K
Cash from discontinued financing activities
Financing cash flow 77.98%14.81M--8.32M
Net cash flow
Beginning cash position -20.79%9.06M--11.44M
Current changes in cash 286.61%4.37M---2.34M
Effect of exchange rate changes 91.72%-2.88K---34.73K
End cash Position 48.24%13.43M--9.06M
Free cash from 2.15%-10.44M---10.67M
Accounting Standards US-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg